New drug may cut transfusions after stem cell transplant
NCT ID NCT07450313
First seen Mar 07, 2026 · Last updated May 09, 2026 · Updated 5 times
Summary
This study tests if luspatercept can improve anemia in 20 adults with blood cancers who had a stem cell transplant. The goal is to reduce the need for red blood cell transfusions. Participants must be 18-60 and have low hemoglobin after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSCT are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.